{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:32:44Z","timestamp":1773804764706,"version":"3.50.1"},"reference-count":135,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T00:00:00Z","timestamp":1602288000000},"content-version":"unspecified","delay-in-days":69,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Millennium Pharmaceuticals, Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2020,8,2]]},"DOI":"10.1080\/17474086.2020.1793666","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T18:40:18Z","timestamp":1596566418000},"page":"907-922","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review"],"prefix":"10.1080","volume":"13","author":[{"given":"Mehul","family":"Dalal","sequence":"first","affiliation":[{"name":"Global Evidence & Outcomes - Oncology, Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Gupta","sequence":"additional","affiliation":[{"name":"Global Access, Decision Resources Group, Gurugram, Haryana, 122002, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Price","sequence":"additional","affiliation":[{"name":"Global Access, Decision Resources Group, 6 Talisman Business Centre, Bicester, Oxfordshire, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Zomas","sequence":"additional","affiliation":[{"name":"Global Medical Affairs - Oncology, Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Miao","sequence":"additional","affiliation":[{"name":"Clinical Sciences , Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajibade","family":"Ashaye","sequence":"additional","affiliation":[{"name":"Global Evidence & Outcomes - Oncology, Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"issue":"1","key":"cit0001","first-page":"nrc2542","volume":"9","author":"K\u00fcppers R.","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy080"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-5149(03)00039-X"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.515979"},{"issue":"4","key":"cit0005","first-page":"232","volume":"36","author":"DeVita VT","year":"1967","journal-title":"Med Ann District Columbia"},{"key":"cit0006","first-page":"CD007941","volume":"5","author":"Skoetz N","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022473"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1186"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.7243"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.99.010"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.138388"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-644336"},{"key":"cit0013","unstructured":"US Food and Drug Administration. FDA news release. FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy. Available at: https:\/\/wwwfdagov\/news-events\/press-announcements\/fda-expands-approval-adcetris-first-line-treatment-stage-iii-or-iv-classical-hodgkin-lymphoma . 2018."},{"key":"cit0014","unstructured":"Takeda. European Commission Approves ADCETRIS\u00ae (brentuximab vedotin) with AVD, the first new treatment in decades for adults with previously untreated CD30+ stage IV Hodgkin lymphoma. News release Feb 2019. Available at https:\/\/wwwtakedacom\/newsroom\/newsreleases\/2019\/european-commission-approves-adcetris-with-avd-for-adults-with-previously-untreated-cd30-stage-iv-hodgkin-lymphoma\/. 2019."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"cit0016","unstructured":"National Institute of Clinical Excellence N. Single technology appraisal: user guide for company evidence submission template. 2017 [cited 2020]. Available from: https:\/\/www.nice.org.uk\/process\/pmg24\/chapter\/instructions-for-companies."},{"key":"cit0017","unstructured":"(CRD). CfRaD. Systematic reviews CRD\u2019s guidance for undertaking reviews in health care 2009 [cited 2020]. Available from: http:\/\/www.york.ac.uk\/inst\/crd\/pdf\/Systematic_Reviews.pdf"},{"issue":"7","key":"cit0018","first-page":"645","volume":"83","author":"Anselmo AP","year":"1998","journal-title":"Haematologica"},{"issue":"12","key":"cit0019","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1002\/cncr.23979","volume":"113","author":"Arakelyan N","year":"2008","journal-title":"Cancer"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500063229"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi023"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059356"},{"issue":"32","key":"cit0023","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1200\/JCO.2010.33.9549","volume":"29","author":"Borchmann P","year":"2011","journal-title":"J Clin Oncol"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-6-739"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272102"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.5648"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.577.577"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/13.S1.102"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.9799"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1638"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.12.3810"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8820"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.086"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61940-5"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.0910"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.4817"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90956-V"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.19"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.907"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4803"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12222"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.3239"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2151"},{"key":"cit0044","first-page":"125","volume":"31","author":"Kriachok IA","year":"2013","journal-title":"Hematol Oncol"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1992.11718238"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu189"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh046"},{"issue":"2","key":"cit0048","first-page":"55","volume":"2","author":"Viviani S","year":"1991","journal-title":"Ann Oncol"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950220304"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000067729"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10932"},{"issue":"7","key":"cit0052","first-page":"722","volume":"85","author":"Gobbi PG","year":"2000","journal-title":"Haematologica"},{"key":"cit0053","first-page":"83","volume":"80","author":"Grozea PN","year":"1982","journal-title":"Recent results cancer res Fortschr der Krebsforschung Progr\u00e8s dans les recherches sur le cancer"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1778"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609098523"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.8.1409"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058255"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.107"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100340"},{"key":"cit0060","unstructured":"Borchmann P, Goergen H, Kobe C, et al. Treatment reduction in patients with advanced-stage hodgkin lymphoma and negative interim pet: final results of the international, randomized phase 3 trial HD18 by the German hodgkin study group. In: Presidential Symposium:European Hematology Association; 2017June23. Abstract S150"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_52"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32134-7"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30103-1"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7539"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7539"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_53"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7541"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7534"},{"key":"cit0071","unstructured":"Hutchings M, Radford J, Gallamini A, et al. Brentuximab vedotin plus chemotherapy in high risk advanced-stage classical Hodgkin lymphoma (CHL) patients: results of pre-specified sub-group analyses from the ECHELON-1 STUDY. European Hematology Association. Abstract S112. Sweden. 2018."},{"key":"cit0072","doi-asserted-by":"crossref","unstructured":"Casasnovas O, Brice P, Bouabdallah R, et al. Final analysis of the AHL2011 randomized phase iii LYSA study comparing an early pet driven treatment de-escalation to a not pet-monitored strategy in patients with advanced stages Hodgkin lymphoma. Abstract S110. European Hematology Association. Sweden. 2018.","DOI":"10.1200\/JCO.2018.36.15_suppl.7503"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7503"},{"issue":"2","key":"cit0074","first-page":"S119","volume":"44","author":"Kobe C","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"cit0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000479566","volume":"40","author":"Kreissl SGH","year":"2017","journal-title":"Abstracts Oncol Res Treat"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30696-4"},{"key":"cit0077","unstructured":"Gallamini A, Radford J, Jurczak W, et al. Frontline brentuximab vedotin plus chemotherapy exhibits superior modified progression-free survival vs chemotherapy alone in patients with stage iii or iv Hodgkin lymphoma: phase 3 ECHELON-1 study. European Hematology Association. Abstact PS1182. Sweden. 2018."},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2543"},{"key":"cit0079","volume-title":"T001. Haematologica: 10th International Symposium on Hodgkin Lymphoma","author":"von Tresckow B","year":"2016"},{"issue":"8","key":"cit0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/medicina45080080","volume":"45","author":"Aleknavicius E","year":"2009","journal-title":"Medicina (Kaunas)"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-011-9494-4"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12364"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008232228653"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.975804"},{"issue":"3","key":"cit0085","first-page":"341","volume":"135","author":"Cabrera ME","year":"2007","journal-title":"Revista Medica De Chile"},{"key":"cit0086","first-page":"573","volume":"98","author":"Chichoune S","year":"2013","journal-title":"Haematologica"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr385"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08485.x"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv077"},{"key":"cit0090","first-page":"258","volume":"33","author":"Gupta S","year":"2015","journal-title":"Hematol Oncol"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.4264"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.150446"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2611-4"},{"issue":"21","key":"cit0094","volume":"124","author":"Kedmi M","year":"2014","journal-title":"Blood Conference: 56th Annual Meeting of the American Society of Hematology, United States 2018. Abstract. ASH"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-100103843"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.603444"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2015_075"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12862"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-014-1268-2"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.9774"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70501-1"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp337"},{"issue":"8","key":"cit0103","first-page":"2704","volume":"91","author":"Gobbi PG","year":"1998","journal-title":"Blood"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1707"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.5.972"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh012"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04962.x"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058431"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1080\/10428190903161075"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-405456"},{"key":"cit0111","volume-title":"Haematologica: 10th International Symposium on Hodgkin Lymphoma","author":"Russo F","year":"2016"},{"key":"cit0112","volume-title":"22nd Congress of the European Hematology Association","author":"Andjelic B","year":"2017"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.01.003"},{"issue":"1","key":"cit0114","first-page":"2799","volume":"130","author":"Damlaj M","year":"2017","journal-title":"Blood"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14734"},{"key":"cit0116","volume-title":"Haematologica: 10th International Symposium on Hodgkin Lymphoma","author":"Evens AM","year":"2016"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-787200"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S160404"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx005"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2439_59"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx524"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70483-2"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0139"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109057990"},{"key":"cit0126","unstructured":"Phillippo DM, Ades AE, Dias S, et al. NICE DSU technical support document 18: methods for population-adjusted indirect comparisons in submission to NICE. 2016 [cited 2020]. Available from http:\/\/nicedsu.org.uk\/"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5807"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/656013"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/952698"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.167478"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-740332"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0634"},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V104.11.1317.1317"},{"issue":"9","key":"cit0134","first-page":"Cd012643","volume":"16","author":"Aldin A","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2018.1426877"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2020.1793666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T13:10:50Z","timestamp":1620479450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2020.1793666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,2]]},"references-count":135,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,2]]}},"alternative-id":["10.1080\/17474086.2020.1793666"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2020.1793666","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}